doi:10.3969/j.issn.1673-8640.2020.06.015

Abstract

CLC Number:

R446

Figures/Tables 2

References 15

[1]	O'DONNELL M R,TALLMAN M S,ABBOUD C N,et al. Acute myeloid leukemia,version 3.2017,NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw,2017,15(7):926-957.
[2]	SWOLIN B,SIMONSSON P,BACKMAN S,et al.Differential counting of blood leukocytes using automated microscopy and a decision support system based on artificial neural networks-evaluation of DiffMaster TM Octavia[J]. Clin Lab Haematol,2003,25(3):139-147.
[3]	YU H,OK C Y,HESSE A,et al.Evaluation of an automated digital imaging system,Nextslide Digital Review Network,for examination of peripheral blood smears[J]. Arch Pathol Lab Med,2012,136(6):660-667.
[4]	BILLARD M,LAINEY E,ARMOOGUM P,et al.Evaluation of the CellaVision DM automated microscope in pediatrics[J]. Int J Lab Hematol,2010,32(5):530-538.
[5]	RIEDL J A,STOUTEN K,CEELIE H,et al.Interlaboratory reproducibility of blood morphology using the digital microscope[J]. J Lab Autom,2015,20(6):670-675.
[6]	叶向军,卢兴国. 2016年更新版《WHO造血和淋巴组织肿瘤分类》之髓系肿瘤和急性白血病修订解读[J]. 临床检验杂志,2016,34(9):686-689.
[7]	尚红,王毓三,申子瑜. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015.
[8]	张昕. 血液细胞形态学检查对提高临床诊断的意义[J]. 临床医药文献电子杂志,2017,4(13) :2532.
[9]	赵锐. 血细胞形态学检验诊断现状及检验质量的提高[J]. 中国药物与临床,2018,18(7) :1128-1130.
[10]	巴哈古丽·王素甫,苏巴提. 外周血异常红细胞形态学检验降低血液病漏诊和误诊价值探讨[J]. 医药卫生,2016,2(5):6.
[11]	胡玲. 血液细胞形态学误诊与漏诊分析[J]. 中国医学工程,2015,23(12) :133.
[12]	BROWN P A,SHAH B,FATHI A,et al.NCCN guidelines insights:acute lymphoblastic leukemia,version 1. 2017[J]. J Natl Compr Canc Netw,2017,15(9):1091-1102.
[13]	GOMEZ-GELVEZ J C,KRYVENKO O N,CHABOT-RICHARDS D S,et al. Comparative analysis reveals potential utility of digital microscopy in the evaluation of peripheral blood smears with some barriers to implementation[J]. Am J Clin Pathol,2015,144(1):68-77.
[14]	贡金英,李元媛,李承文,等. 免疫表型分析及分子遗传学在急性早幼粒细胞白血病诊断中的应用[J]. 中华血液学杂志,2019,40(4):288-293.
[15]	顾桂颖,刘景鑫,石张镇,等. 计算机图像识别在白血病形态学诊断中的应用[J]. 中国医疗设备,2018,33(6):6-11.

方法	例数	中性粒细胞	淋巴细胞	单核细胞	嗜酸性粒细胞	嗜碱性粒细胞	异常细胞
血涂片院内镜检	68	56.70±5.21	34.22±11.03	7.01±3.45	0.81±0.99	1.42±1.14	18.53±2.06
血涂片数字化检查	68	57.70±6.02	34.66±10.89	6.89±4.32	0.88±1.21	1.55±1.08	17.69±2.17
血涂片数字化结合网络会诊	68	55.50±5.33	37.06±13.22	6.66±3.52	0.73±0.08	1.38±0.94	18.27±1.74
F值		1.04	0.23	0.18	0.37	0.47	0.38
P值		>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

方法	例数	中性粒细胞	淋巴细胞	单核细胞	嗜酸性粒细胞	嗜碱性粒细胞	异常细胞
血涂片院内镜检	68	56.70±5.21	34.22±11.03	7.01±3.45	0.81±0.99	1.42±1.14	18.53±2.06
血涂片数字化检查	68	57.70±6.02	34.66±10.89	6.89±4.32	0.88±1.21	1.55±1.08	17.69±2.17
血涂片数字化结合网络会诊	68	55.50±5.33	37.06±13.22	6.66±3.52	0.73±0.08	1.38±0.94	18.27±1.74
F值		1.04	0.23	0.18	0.37	0.47	0.38
P值		>0.05	>0.05	>0.05	>0.05	>0.05	>0.05

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	ZHOU Ying, REN Yihui, LI Guangming. Serum miR-148a expression in children with autoimmune hepatitis and its correlation with inflammatory factors [J]. Laboratory Medicine, 2023, 38(12): 1130-1134.
[5]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[6]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[7]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[9]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[10]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[11]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[12]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[13]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.